Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.
D000249:Adenosine Monophosphate / Q000096:biosynthesis; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000473:pathology; D002471:Cell Transformation, Neoplastic; D003854:Deoxyribonucleotides / Q000378:metabolism; D005786:Gene Expression Regulation; D005943:Gluconeogenesis; D006157:Guanosine Monophosphate / Q000096:biosynthesis; D006801:Humans; D007291:Inosine Monophosphate / Q000096:biosynthesis; D007555:Isoxazoles / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000378:metabolism; D008113:Liver Neoplasms; D008115:Liver Regeneration; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D011687:Purines / Q000378:metabolism; D011743:Pyrimidines / Q000378:metabolism; D012265:Ribonucleotides / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003854:Deoxyribonucleotides; D007555:Isoxazoles; D011687:Purines; D011743:Pyrimidines; D012265:Ribonucleotides; D007291:Inosine Monophosphate; D000249:Adenosine Monophosphate; D006157:Guanosine Monophosphate; C006303:acivicin